Frequency and clinical relevance of EGFR mutations and EML4–ALK translocations in octogenarians with non-small cell lung cancer

BACKGROUND: Tyrosine kinase inhibitors (TKIs) have improved response rates in some patients with non-small cell lung cancer (NSCLC), and testing for EGFR mutation and ALK translocation is recommended for all patients with advanced lung adenocarcinoma. The frequency of driver mutations in elderly and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tufman, Amanda, Kahnert, Kathrin, Duell, Thomas, Kauffmann-Guerrero, Diego, Milger, Katrin, Schneider, Christian, Stump, Julia, Syunyaeva, Zulfiya, Huber, Rudolf Maria, Reu, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661834/
https://www.ncbi.nlm.nih.gov/pubmed/29123416
http://dx.doi.org/10.2147/OTT.S140472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661834/
https://www.ncbi.nlm.nih.gov/pubmed/29123416
http://dx.doi.org/10.2147/OTT.S140472

Ejemplares similares